Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder that typically begins in early childhood and often persists into adolescence and adulthood. It affects brain development and functioning, particularly in areas responsible for attention, impulse control, and executive functioning.

ADHD is characterized by persistent patterns of inattention, hyperactivity, and/or impulsivity that interfere with functioning or development. These behaviors are more frequent and severe than typically observed in children of the same age and developmental level.

ADHD is not caused by laziness or poor parenting. It is a biologically based condition involving differences in brain structure and neurotransmitter activity, particularly dopamine and norepinephrine.

Other Name(s)

ADD (Attention-Deficit Disorder) – outdated term, often used to describe inattentive type

Hyperkinetic Disorder (used in some European contexts)

Neurodevelopmental Disorder (clinical classification)

Difference Between ADHD and Similar Conditions

Difference Between Normal and Abnormal Behavior

Types of ADHD

Predominantly Inattentive Type

Difficulty sustaining attention

Easily distracted, forgetful

Often mislabeled as “daydreamers”

Predominantly Hyperactive-Impulsive Type

Excessive movement, talking

Impulsive decisions, interrupting

Combined Type

Symptoms of both inattention and hyperactivity/impulsivity

Most common presentation

Causes

Genetics: Strong hereditary component

Brain Structure & Function: Differences in frontal lobe activity and neurotransmitter levels

Prenatal Factors: Exposure to tobacco, alcohol, or lead during pregnancy

Premature Birth or Low Birth Weight

Risk Factors

Family history of ADHD or other mental health disorders

Environmental toxins (e.g., lead)

Maternal substance use during pregnancy

Early childhood trauma or neglect

Male sex (boys are diagnosed more often)

Who Is Vulnerable?

Children aged 3–12 (symptoms typically emerge before age 12)

Boys are diagnosed 2–3x more often than girls, though girls may be underdiagnosed

Children with co-occurring conditions (e.g., anxiety, learning disabilities)

Complications

Academic underachievement

Social isolation or peer rejection

Low self-esteem

Increased risk of substance use disorders

Higher rates of injury and accidents

Legal or disciplinary issues in adolescence

Prevention

While ADHD cannot be fully prevented, risk may be reduced by:

Avoiding alcohol, tobacco, and drug use during pregnancy

Reducing exposure to environmental toxins

Early intervention and behavioral support

How the Condition Develops

ADHD symptoms typically begin in early childhood and evolve over time:

Preschool: hyperactivity, impulsivity

School-age: academic and social challenges

Adolescence: emotional regulation, risk-taking behaviors

Common Symptoms

Inattention: distractibility, forgetfulness, poor organization

Hyperactivity: fidgeting, excessive talking, restlessness

Impulsivity: interrupting, acting without thinking, impatience

Other Conditions That Mimic ADHD

Anxiety disorders

Depression

Sleep disorders

Learning disabilities

Hearing or vision impairments

Diagnosis and Tests

Clinical evaluation using DSM-5 criteria

Parent and teacher rating scales (e.g., Vanderbilt, Conners)

Developmental history

Rule out other conditions (e.g., hearing/vision tests)

Treatment and Therapies

Statistics & Disparities

~11% of U.S. children aged 3–17 have been diagnosed

Boys (15%) more likely than girls (8%)

Black and White children diagnosed more often than Asian children

Disparities exist in diagnosis and treatment access across racial and socioeconomic groups

Alternative/Complementary Treatments

Omega-3 fatty acids

Mindfulness and meditation

Neurofeedback

Dietary modifications (limited evidence)

New Medications

Viloxazine (Qelbree) – non-stimulant approved for children

Extended-release formulations for once-daily dosing

Cost of Treatment

Medication: $30–$200/month depending on brand and insurance

Therapy: $100–$200/session

Educational services: varies by school district

Insurance Coverage

Most private and public insurance plans cover ADHD evaluation and treatment

Coverage varies for therapy, medication, and educational services

Prognosis

With treatment, many children lead successful lives

Symptoms may persist into adulthood but can be managed

Early intervention improves long-term outcomes

What Happens Without Treatment?

Increased risk of academic failure

Poor peer relationships

Emotional and behavioral problems

Higher likelihood of substance abuse and legal issues

Related Images

Images typically include:

Brain scans showing structural differences

Behavioral infographics

Classroom behavior illustrations

Survival Rate / Mortality Rate

ADHD is not a fatal condition, but untreated ADHD is associated with:

Increased risk of accidental injury

Higher rates of substance use and suicide

Palliative Care

Not applicable in traditional sense; however, supportive care includes:

Emotional support

Family counseling

School accommodations

Living with ADHD

Structure and routine are key

Positive reinforcement strategies

Advocacy in school and healthcare settings

Peer support and education

New Treatment Approaches

Digital therapeutics (e.g., FDA-approved video games for attention training)

Genetic testing for medication response

Parent coaching apps and platforms

Related Issues

Sleep disorders

Executive function deficits

Emotional dysregulation

Co-occurring conditions (e.g., anxiety, depression)

Ongoing Research

Neuroimaging studies

Genetic markers

Long-term outcomes of stimulant use

Impact of early intervention

Clinical Trials

To participate:

Visit ClinicalTrials.gov

Search “ADHD children”

Contact local academic hospitals or ADHD centers

Additional Information & Support

CDC ADHD Resources

CHADD – Children and Adults with ADHD

National Institute of Mental Health ADHD Page

Understood.org – ADHD and Learning

ADHD Foundation UK

ADDitude Magazine

Source: America Healthline Medical Team